Cleared Traditional

K233056 - EpiZact (FDA 510(k) Clearance)

Nov 2023
Decision
38d
Days
Class 2
Risk

K233056 is an FDA 510(k) clearance for the EpiZact. This device is classified as a Syringe, Piston (Class II - Special Controls, product code FMF).

Submitted by Guidestar Medical Devices (Victoria, CA). The FDA issued a Cleared decision on November 2, 2023, 38 days after receiving the submission on September 25, 2023.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K233056 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 25, 2023
Decision Date November 02, 2023
Days to Decision 38 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code FMF - Syringe, Piston
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860

Similar Devices - FMF Syringe, Piston

All 21
Profoject™ Insulin Syringes
K253068 · CMT Health PTE., Ltd. · Feb 2026
Verisafe Safety Retractable Insulin Syringes
K250192 · Promisemed Hangzhou Meditech Co., Ltd. · Dec 2025
Merit Syringe
K250853 · Merit Medical Systems, Inc. · Nov 2025
Monoject™ 1mL Tuberculin Syringe Luer-Lock Tip (1180100777)
K243660 · Cardinalhealth · Aug 2025
BD Plastipak™ Syringe
K251350 · Becton, Dickinson and Company · Jul 2025
GraftGun Universal Graft Delivery System (GDS)
K243580 · SurGenTec, LLC · Feb 2025